March 27 (Reuters) - Federal prosecutors in Manhattan
are probing a claim by GSK that Pfizer delayed
announcing its COVID shot's success in 2020 until after that
year's election, the Wall Street Journal reported, citing people
familiar with the matter.
The report said on Wednesday GSK's former head of vaccine
development, Philip Dormitzer, had told his colleagues about the
delay by Pfizer, where he worked before joining the British
company.
However, Dormitzer has disputed the claims of his former
colleagues.
"My Pfizer colleagues and I did everything we could to get
the FDA's Emergency Use Authorization at the very first possible
moment. Any other interpretation of my comments about the pace
of the vaccine's development would be incorrect," Dormitzer told
Reuters.
The WSJ report said the U.S. Attorney's Office for the
Southern District of New York, which includes Manhattan, is
taking a closer look at GSK's claims.
"We cannot comment because we have not received any inquiry
from authorities about a so-called 'delay,' but Pfizer remains
ready, willing, and able to explain why any allegation of
impropriety is utter nonsense," Pfizer told Reuters.
U.S. President Donald Trump has claimed in the past that
Pfizer sat on positive data from the vaccine's clinical trials,
but there was no evidence.
"We have consistently and transparently reiterated the facts
and the timeline of the tireless work of scientists, regulators,
and thousands of clinical trial volunteers who made the vaccine
possible. Theories to the contrary are simply untrue," Pfizer
said.
The U.S. Attorney's Office in Manhattan has interviewed at
least two people, including a GSK executive who took notes of a
conversation with Dormitzer, the report said.
The prosecutors are planning more interviews in the coming
days, the report said, adding that Pfizer officials have not yet
been interviewed.
GSK declined to comment, while the U.S. Attorney's Office
did not immediately respond to Reuters' requests for comments.
(Reporting by Puyaan Singh and Mariam Sunny in Bengaluru;
Additional reporting by Michael Erman; Editing by Shreya Biswas
and Shinjini Ganguli)